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Abstract: The aim of this experimental study
was to determine the effects of growth
hormone on hepatic regeneration after
partial hepatectomy.
Thirty pathogen free Sprague-Dawley rats
were divided into three groups, each
containing 10 rats.
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The animals were subjected to a sham
operation in Group 1, and to left hepatic
lobectomy in Groups 2 and 3. The animals in
Groups 1 and 2 received saline solution (0.2
mg/kg/day), while growth hormone (Lilly
Humotrope, Lilly France Usine de
Fegersheim, France) (0.2 mg/kg/day) was
given to the animals in Group 3 for seven

Introduction
Regeneration of normal and injured liver is one of the
most important issues in hepatology and hepatic surgery
(1).
The polygonal cells of the mammalian liver have a high
regeneration capacity. After partial hepatectomy, the
regeneration lasts until the liver reaches sufficient volume
(2).
Because of the vast functional reserve of the liver and
its regeneration capacity, an extensive hepatic resection
to remove 80% of the liver can be tolerated by most
patients with a normal liver (3). Hepatic regeneration or
restorative hyperplasia is an interesting subject for
research (3,4). Although there have been reports about
metabolic changes and hepatotrophic factors, the
pathophysiology of regeneration is unclear (3-6).
Hepatocytes exhibit mitosis very rarely, but 24 hours
after partial resection, cell replication occurs and stops

days. On the seventh postoperative day, the
animals were sacrificed and total
hepatectomy was performed. The mitosis
rate of the hepatocytes and Ki-67
monoclonal antibody positivity were
determined.
The animals in Group 3 exhibited a higher
hepatocyte mitosis rate and greater Ki-67
monoclonal antibody positivity than the
animals in Groups 1 and 2. It was concluded
that the growth hormone had positive effects
on hepatic regeneration.
Key Words: Growth hormone, hepatic
regeneration.

when the liver reaches its initial mass. This process lasts
approximately 4-5 weeks. Humoral factors from the
injured liver and other organs lead to hepatic
regeneration (3-8). These factors are insulin, glucagon,
hypophysial hormones, and arginin (2,5,6).
Growth hormone (GH) is one of the hormones of the
somatolactogen family and is an anabolic hormone that
improves protein metabolism in critical illness. GH is also
the major regulator stimulating the synthesis and
secretion of insulin like growth factor-1 (IGF-1) from
various tissues. The anabolic effects of GH on protein
metabolism are mainly mediated by IGF-1 (9-12)
Ki-67 is a human nuclear antigen that is present in
proliferating cells, but is absent in resting cells (13)
In order to investigate the effects of growth hormone
on hepatic regeneration after partial hepatectomy, an
experimental study was performed, and mitosis rate and
Ki-67 antibody positivity were investigated
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Materials and Methods
Thirty pathogen free Sprague-Dawley rats weighing
250±25gr were fasted for 12 hours before the
operation. Under aseptic conditions anesthesia was
performed with intramuscular ketamine HCl (30mg/kg).
The animals were divided into three groups, each
containing 10 animals.
Group 1 (sham operation): Laparotomy was
performed and then the liver was delivered from the
abdomen by compressing the ribs. It was then replaced in
the abdomen and the abdomen was closed with 3/0 silk.
The animals received 0.2 mg/kg/day saline solution
subcutaneously for seven days.
Group 2: The animals were subjected to left
hepatectomy and received saline solution of
0.2mg/kg/day for seven days.
Group 3: The animals were subjected to left
hepatectomy and received growth hormone (Lilly
Humotrope, Lilly France Usine de Fegersheim, France) of
0.2mg/kg/day for seven days.
On the seventh postoperative day, by the injection of
intracardiac 3% gluteraldeyde, the animals were
sacrificed and total hepatectomy was performed. The
livers were fixed in 10% formaldehyde solution and
subjected to the standard procedure for paraffin
embedding. In order to determine the mitosis rate, 4-µm
thick sections were stained with H&E and examined
under light microscopy. The mitosis rate was determined
by random evaluation of at least 1000 hepatocytes and
was expressed as a percentage (number of cells with
mitosis/total number of hepatocyte cells X 100).
In order to determine Ki-67 antibody positivity, 4-µm
sections were stained with Ki-67 monoclonal antibody
(Biogenex, AM297-5m, USA) and Ki-67 positivity was
determined as described previously (14). The results
were expressed as a percentage (number of cells with
mitosis/total number of hepatocyte cells X 100).

3 were similar, and there was granulation around the
wounds. The mitosis rate was 18% in Group 2 (Figure 2)
and 33% in Group 3 (Figure 3). Statistical analysis
showed significant differences in mitosis between Group
1 and Group 2, Group 1 and Group 3, and Group 2 and
Group 3 (p<0.01) (Table 1).
Table 1.

Mitosis rates
Groups

Mitosis rate (%)

Group 1
Group 2
Group 3

0*
18±1.53*
33±2.52*

*p<0.01 as compared with the other groups

Ki-67 antibody positivity was 3.5% in Group 1,
20.4% in Group 2 (Figure 4) and 27.6% in Group 3
(Figure 5). Statistical analysis showed significant
differences in the Ki-67 antibody rate between Group 1
and Group 2, Group 1 and Group 3 (p<0.01), and Group
2 and Group 3 (p<0.05) (Table 2).
Table 2.

Ki-67 positivity
Groups

Ki-67 positivity (%)

Group 1
Group 2
Group 3

3.5±0.17*
20.4±1.08**
27.6±1.96

*p<0.01 as compared with the other groups,
**p<0.05 as compared with Group 3

An Arc.Sin transformation was carried out on the
results, which were expressed as a percentage, and then
a variant analysis and LSD post hoc test were used for
statistical analysis, with p<0.05 considered significant.
Results
Two animals in Group 2 and one in Group 3, died in
the postoperative period and were excluded. The livers in
Group 1 exhibited no macroscopic changes and no mitosis
in the hepatocytes on microscopic examination (Figure1).
The macroscopic appearance of the livers in Groups 2 and
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Figure 1.

Absence of mitosis in Group 1 (H&EX100)
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Figure 2.

Regenerative changes in Group 2 (H&EX200)

Figure 5.

Mitotic activities in Group 3 (Ki-67X400)

Discussion
The liver has many important metabolic functions
which have an influence on other organs and systems.
Today, hepatic surgery is carried out in major medical
establishments for reasons of either preoperative
preparation or postoperative care and dealing with
complications (1).

Figure 3.

Figure 4.

Regenerative changes in Group 3 (H&EX200)

Mitotic activities in Group 2 (Ki-67X400)

Mortality in elective hepatic surgery is aproximately
5% and is generally related to postoperative
complications (3,15-17). Hepatic resection impairs
metabolic, immunologic, coagulative, cardiovascular,
respiratory and renal functions (18,19). Multisystem
organ failure, which has a 30-100% mortality rate,
occurs at a rate of 7 to 22% due to these metabolic
changes (20-22).
Regeneration of the mammalian liver has been studied
for many years (23). The differences between the
regeneration of the normal and injured liver is one of the
main issues in hepatology and hepatic surgery. Studies of
humans and animals have highlighted many technical
difficulties (24). DNA synthesis and enzymatic activities,
like ornithine decorboxilase, thymidine kinase, and
polyamine oxydase, are used as markers in hepatic
regeneration in vitro, but in vivo these markers are not
adequate (23). Despite all these diffuculties, it has been
observed that regeneration of the liver is common after
partial hepatectomy. However, the many factors involved
in regeneration are less understood. There have been
many reports related to the series of metabolic changes
and to hepatotrophic factors (3-6). It has been shown
that regeneration in the remaining liver tissue after
partial hepatectomy starts on the first day (3,25-28).
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In those studies which have aimed to determine the
regeneration criteria, many different markers and
materials have been used. These consist of: DNA synthesis
and mitosis number, liver volume, cell proliferation,
mitochondrial activity, DNA thymidine content, 5bromo,2-dioxyuridine, proliferating cell nuclear antigen
(PCNA), plasma fibronectin level, and stimulator
substance (10,25,29,30).
In order to evaluate the effects of hepatocyte growth
factors on hepatic regeneration, many studies have been
performed. It has been shown that hepatocyte growth
factor promotes liver regeneration, ameliorates
hyperbilirubinemia in hepatectomized cholestatic rats,
and prevents postoperative liver failure (31,32). In the
present study, we aimed to evaluate the effects of GH on
liver regeneration in hepatectomized rats.

membrane, which demonstrates that GH directly affects
the GI tract and causes proliferation. In our study, we did
not have the opportunity to determine GH receptor in the
liver, but we found that the group which recieved GH
after partial hepatectomy had a higher level of Ki-67
antibody positivity, which was used as a marker of
mitosis rate and cell proliferation (p<0.01). This situation
may be due to the higher regeneration rate in the group
which received GH.
Studies have shown that GH increases protein
synthesis by increasing mRNA in the nucleus, and
promotes cell growth and proliferation (12, 38, 40). In
our study, the high level of Ki-67 monoclonal antibody
positivity in the study group compared to the controls
(p<0.05) may be due to completion of the cell cycle and
proliferation.

Gerders et al. (13), in 1983, found Ki-67 antigen and
monoclonal antibody against it in the cell nucleus. In
prognostic conditions, this antibody shows a correlation
with central nervous system tumors (glioma,
olygodendroglioma, pineoblastoma, primary central
nervous system lymphoma and neurofibroma), nonHodgkin lymphoma, soft tissue sarcomas and carcinoma
of the breast. Ki-67 differs from other methods and
materials in terms of its value in the classification of the
whole cycle, rather than the "S phase" only. This
classification is used as a sign of cell proliferation (12,13,
33-37).

IGF-I and IGF-II, which are known as somatomedins,
mediate GH in anabolic and growth effects. In particular,
IGF-I mediates many interactions (38,41)

After the period of fetal life, the liver becomes rich in
GH receptors, and contains few IGF-1 receptors.
Therefore, most effects of GH are localized in the liver (9,
38). In addition, it has been discovered that there is a
high concentration of GH receptors in this tissue (3). It
has also been reported that GH accelerates cell protein
synthesis by increasing mRNA synthesis in the cell and
shows an increasing effect on the target tissue (39).

Inoue et al. (12) reported that rats with sepsis
showed a decrease in the number of bacteria and greater
survival when treated with GH. Edwards et al. (42)
reported that GH has positive effects on immunity,
protein metabolism and wound healing. In our study, we
determined a higher mitosis rate in the study group than
in the controls (p<0.01). The higher level of Ki-67
monoclonal antibody positivity (p<0.05) and the results
given above are similar to those of other studies.

There is evidence that GH takes on the role of
continuity of the structure and function of intestinal
mucous membrane and stimulates the proliferation of the
mucous membrane epithelium. Gomez de Segura et al.
(10) evaluated the effect of GH on the proliferation of the
mucous membrane of rat intestine. They reported that
GH receptors were found in the intestinal mucous

Huang et al. (41) reported that body weight,
intestinal mucous membrane thickness, and mucosal DNA
and protein were higher in IGF-treated burned rats than
in the controls, and they concluded that GH both directly
and, by increasing IGF-I levels, indirectly prevents
mucosal atrophy. Although we did not use any
parameters to determine the effect of GH on the liver,
the higher mitosis rate (p<0.01) in the GH-treated group
shows a correlation with those results.

On the basis of these results, after partial
hepatectomy, GH increases hepatocyte regeneration in
the early stages. However, the present study must be
supported by further experimental and clinical studies.
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